Detalles de la búsqueda
1.
MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma.
Front Oncol
; 13: 1130034, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36895472
2.
Combined targeting of the p53 and pRb pathway in neuroblastoma does not lead to synergistic responses.
Eur J Cancer
; 142: 1-9, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33190064
3.
High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma Cells.
Mol Cancer Ther
; 20(6): 1161-1172, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33850004
Resultados
1 -
3
de 3
1
Próxima >
>>